Novavax NVAX Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Novavax in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Novavax's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Novavax's total costs & expenses?
- Novavax (NVAX) reported total costs & expenses of $154.94M in Q1 2026.
- How has Novavax's total costs & expenses changed year-over-year?
- Novavax's total costs & expenses increased by 2.5% year-over-year, from $151.14M to $154.94M.
- What is the long-term trend for Novavax's total costs & expenses?
- Over 4 years (2021 to 2025), Novavax's total costs & expenses has grown at a -30.2% compound annual growth rate (CAGR), from $2.83B to $670.68M.
- What does total costs & expenses mean?
- This metric aggregates all operating costs incurred by the company to generate revenue, including cost of goods sold, research and development, and selling, general, and administrative expenses. It serves as a comprehensive measure of the company's operational burn rate and cost structure. Analyzing this figure allows stakeholders to evaluate management's ability to control expenditures relative to revenue growth and overall operational efficiency.